Your new experience awaits. Try the new design now and help us make it even better

BRIEF RESEARCH REPORT article

Front. Neurol.

Sec. Dementia and Neurodegenerative Diseases

Quantitative evaluation of iron chelator effects on central motor and sensory tracts in superficial siderosis

Provisionally accepted
Ryo  IwaseRyo Iwase1,2NOBUO  SANJONOBUO SANJO1,2*Tadashi  KanouchiTadashi Kanouchi1,2Yurie  NoseYurie Nose1,2Miho  AkazaMiho Akaza1,2Motonori  HashimotoMotonori Hashimoto1,2Satoru  EgawaSatoru Egawa1,2Toshitaka  YoshiiToshitaka Yoshii1,2Takanori  YokotaTakanori Yokota1,2
  • 1Institute of Science Tokyo, Tokyo, Japan
  • 2Tokyo Kagaku Daigaku - Yushima Campus, Bunkyo, Japan

The final, formatted version of the article will be published soon.

Abstract Background Superficial siderosis (SS) is a rare neurodegenerative disease characterized by hemosiderin deposition in the central nervous system, leading to progressive neuronal degeneration. Although myelopathy is a main clinical manifestation in SS, objective biomarkers for monitoring disease progression and treatment remain unclarified. We assessed electrophysiology of central motor and sensory conduction in patients with SS before and after iron chelator administration. Methods In this controlled trial, we evaluated 12 patients with SS (mean follow-up: 33.6 months [range: 18.9– 36.1]), who underwent dural repair, and 9 with multiple sclerosis as controls. Transcranial magnetic stimulation (TMS) and somatosensory evoked potentials (SEPs) were used to assess motor and sensory conduction, respectively. Eight patients with SS received oral iron chelator deferiprone (1,500 mg/day), whereas four underwent surgical repair without iron chelation. Primary outcomes were changes in central motor conduction time (CMCT), motor evoked potential (MEP) amplitude, and central sensory conduction time (CCT). Results At baseline, 92% and 100% of patients with SS exhibited prolonged CMCT and CCT, respectively. Prolonged conduction in patients with SS was less severe than in those with multiple sclerosis (MS).

Keywords: central motor tracts, central sensory tracts, Iron chelator, Quantitative evaluation, Superficial siderosis

Received: 29 Oct 2025; Accepted: 13 Jan 2026.

Copyright: © 2026 Iwase, SANJO, Kanouchi, Nose, Akaza, Hashimoto, Egawa, Yoshii and Yokota. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: NOBUO SANJO

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.